# Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery

> **NCT06361238** · PHASE3 · RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 260 (estimated)

## Conditions studied

- Delirium, Postoperative

## Interventions

- **DRUG:** Liraglutide injection
- **DRUG:** Placebo injection

## Key facts

- **NCT ID:** NCT06361238
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-19
- **Primary completion:** 2027-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2024-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06361238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06361238, "Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06361238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*